Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 9/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 8/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29620969 | 1.00 | KIF11 (0.53) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL22925563 | 0.82 | ABCB1 (0.39) | CYP11B2CYP11B1 | |
| SCHEMBL29620937 | 0.82 | ABCB1 (0.39) | CYP11B2CYP11B1 | |
| SCHEMBL22925797 | 0.82 | CYP11B2 (0.50) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL22925568 | 0.77 | KIF11 (0.48) | KIF11 | |
| SCHEMBL22925714 | 0.73 | RAB9A (0.53) | — | |
| SCHEMBL15311723 | 0.72 | CYP11B2 (0.51) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL21116892 | 0.72 | KIF11 (0.76) | KIF11CYP11B2CYP11B1 | |
| SCHEMBL4524356 | 0.72 | ADORA2A (0.46) | — | |
| SCHEMBL20242220 | 0.71 | TAAR1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220274970-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2022-09-01 | — | — | US | disclosed |
| CN-114450281-A | Inhibitor compounds | 辛塞拉治疗私人有限公司 | 2022-05-06 | — | — | CN | disclosed |
| WO-2021012018-A1 | INHIBITOR COMPOUNDS | Cincera Therapeutics Pty Ltd (AU) | 2021-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220274970-A1 | INHIBITOR COMPOUNDS | SERPINB1, MMP1, SSB | KIF11 4192/4885CYP11B2 2089/4885CYP11B1 1726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.